EVOKE PHARMA, INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 12 rows in 2013. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2013-12-02: Reporting owner Gonyer David A; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2013-12-02: Reporting owner D'Onofrio Matthew J; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2013-12-02: Reporting owner CARLSON MARILYN R.; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2013-09-24: Reporting owner WIDDER KENNETH J; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2013-12-02 | Gonyer David A Director, Officer (President and CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +94,250 94,250 owned after | $8.67 exercise price | 2013-12-03 | |
| 2013-12-02 | D'Onofrio Matthew J Officer (Exec VP, Chief Bus. Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +94,250 94,250 owned after | $8.67 exercise price | 2013-12-03 | |
| 2013-12-02 | CARLSON MARILYN R. Officer (Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +100,000 100,000 owned after | $8.67 exercise price | 2013-12-03 | |
| 2013-09-24 | WIDDER KENNETH J Director, 10% Owner | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +18,000 18,000 owned after | $12.00 exercise price | 2013-09-26 | |
| 2013-09-24 | RHOADS ANN D Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +18,000 18,000 owned after | $12.00 exercise price | 2013-09-26 | |
| 2013-09-24 | Hill Malcolm R Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +18,000 18,000 owned after | $12.00 exercise price | 2013-09-26 | |
| 2013-09-24 | GLENN SCOTT L Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +18,000 18,000 owned after | $12.00 exercise price | 2013-09-26 | |
| 2013-09-24 | GARNER CAM L Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +18,000 18,000 owned after | $12.00 exercise price | 2013-09-26 | |
| 2013-09-24 | Brady Todd C Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +18,000 18,000 owned after | $12.00 exercise price | 2013-09-26 | |
| 2013-09-24 holding as of filing | Hill Malcolm R Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $0.29 exercise price | 2013-09-24 | ||
| 2013-09-24 holding as of filing | Gonyer David A Director, Officer (President and CEO) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $0.40 exercise price | 2013-09-24 | ||
| 2013-09-24 holding as of filing | D'Onofrio Matthew J Officer (Exec VP, Chief Bus. Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $0.40 exercise price | 2013-09-24 |